My research interests are centered on the design and application of biophysical and biochemical assays to unravel the complexities of biology, particularly in the context of rare diseases.

 

Alongside the scientific aspect, I have a keen interest in the business dimension of science, focusing on strategies to effectively engage stakeholders in the collective effort to expedite the translation of rare disease therapeutics from the laboratory to clinical settings.

 

My aim is to bridge the gap between cutting-edge research and practical therapeutic applications, ensuring a streamlined path to clinical trials and, ultimately, patient care.